Compare Charles River Laboratories Intl. Inc (CRL) vs Manulife Financial Corporation (MFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Manulife Financial Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Manulife Financial Corporation trades at $42.43 (market cap $69.48B). The key difference: Manulife Financial Corporation is far larger — about 4.9× Charles River Laboratories Intl. Inc's market cap, and Manulife Financial Corporation pays a 3.23% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Manulife Financial Corporation for 119 Days on average.
| CRL | MFC | |
|---|---|---|
Market Cap | $14.23B | $69.48B |
Volume | 1,176,885 | 1,347,508 |
Sector | Health | Financials |
52-Week High | $310.77 | $44.77 |
52-Week Low | $149.93 | $31.64 |
Typical Hold Time | 33 Days | 119 Days |
Enterprise Value | $17.06B | $64.75B |
Dividend Yield | — | 3.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
MFC trades at $42.43, up 1.82% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings of $0.79 per share, beating expectations by 1.3%, with revenue growth accelerating to $53.01 billion in 2025. Analyst consensus remains bullish with 57% buy ratings, though the current price exceeds the $34.24 consensus target. Recent institutional activity includes Bank of America's $145 million investment in Q2 2026.
MFC demonstrates solid fundamental growth with improving cash flow trends and expanding revenue, though valuation appears stretched relative to analyst targets. Key risks include premium valuation concerns and competitive pressures in financial services. The stock offers exposure to Asia-driven insurance growth but faces headwinds from technical bearish signals and elevated P/E ratio of 16.22.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →
